Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Dec 25;9(4):5301–5320. doi: 10.18632/oncotarget.23685

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2018 Vighi et al.

This article is distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.

PMC Copyright notice

(A–B) VASP phosphorylation at S157 was evaluated in MNT1 cells not treated (NT) or treated with PA4 at 1 μM for 24 h. (A) Immunolocalization of S157 pVASP shows decreased pVASP after treatment. (B) Immunoblotting of pVASP phosphorylated at S157 in MNT1 cells. The immunoblot was normalized by analysis of actin. The histogram at the right-hand side shows quantitative analysis of three replicates. (C–D) VASP phosphorylation at S157 was evaluated in SkMel28 cells not treated (NT) or treated with PA5 at 1 μM for 24 h or 72 h. (C) Immunolocalization of S157 pVASP shows no change after treatment. (D) Immunoblotting of pVASP at S157 in SkMel28 cells after treatment with PA5 at 1 μM for 24 h or 72 h. The immunoblot was normalized by analysis of actin. The histogram shows quantitative analysis of three replicates. Error bars: SD. Statistical comparison: NT vs treated with Student's unpaired two-tailed t-test; Significance levels: p < 0.05 = ^*p < 0.01 = ^**p < 0.001 = ^***.